AstraZeneca Seeks Judgment In Nexium Pay-For-Delay Case
Coming on the heels of a mistrial bid, Ranbaxy Inc. and AstraZeneca PLC moved for judgment Thursday in a pay-for-delay case unfolding in Massachusetts federal court over the heartburn drug Nexium,...To view the full article, register now.
Already a subscriber? Click here to view full article